Clinical Trial Update: Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pembrolizumab in combination with plinabulin and docetaxel for metastatic non-small cell lung cancer after prior immune checkp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Pembrolizumab (pembrolizumab)
• Plinabulin (plinabulin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Non Small Cell Lung Cancer Metastatic | Phase 2 | Status: UNKNOWN